they block HIV from fusing with healthy cells.
There is no cure for HIV, however the drug classes that are used to treat HIV are Non-nucleoside reverse transcriptase inhibitors (NNRTIs), Nucleoside reverse transcriptase inhibitors (NRTIs), Protease inhibitors (PIs), Entry or fusion inhibitors, and Integrase inhibitors
Anti-AIDS drugs, or antiretroviral therapies (ART), work through various mechanisms to inhibit the replication of the HIV virus. Key classes include reverse transcriptase inhibitors, which block the enzyme responsible for converting viral RNA into DNA; protease inhibitors, which prevent the maturation of viral particles; and integrase inhibitors, which stop the integration of viral DNA into the host's genome. Additionally, entry inhibitors prevent the virus from entering host cells, while fusion inhibitors block the fusion of the virus with the host cell membrane. Together, these methods help reduce viral load and improve immune function in infected individuals.
HIV treatments must be promptly administered to anyone diagnosed as HIV positive. These treatments slow down the course of the disease. As per WHO, HIV treatments include use of at least three antiretroviral drugs to suppress the HIV virus. Various classes of drugs that are helpful in HIV treatment are non-nucleoside reverse transcriptase inhibitors, protease inhibitors, integrase inhibitors, entry inhibitors, fusion inhibitors, CCR5 receptor antagonists, maturation inhibitors, etc. The drugs bevirimat and vivecon are being investigated for their benefits in HIV treatment.
to germinate inhibitors
Monoamine oxidase inhibitors
Competitive inhibitors compete with the substrate for the enzyme's active site, while noncompetitive inhibitors bind to a different site on the enzyme. Competitive inhibitors can be overcome by increasing substrate concentration, while noncompetitive inhibitors cannot. Both types of inhibitors reduce enzyme activity, but competitive inhibitors specifically affect the binding of the substrate, while noncompetitive inhibitors can alter the enzyme's shape or function.
They are also called DC inhibitors
They are also called DC inhibitors
COMT inhibitors include entacapone and tolcapone
They are inhibitors of the enzyme monoamine oxidase B
Yes, enzyme reactions can be slowed or halted using inhibitors. Inhibitors can bind to the enzyme and prevent it from binding to its substrate, thus inhibiting the reaction. There are different types of inhibitors, such as competitive inhibitors that compete with the substrate for binding to the enzyme, and non-competitive inhibitors that bind to a different site on the enzyme and alter its shape or function.
They are also called Angiotensin-converting enzyme inhibitors